According to financial reports for the second quarter, ESAB posted revenue of $807.6 million, beating analyst estimates of $787.2 million and delivering 12.9% year-on-year growth, driven primarily by strong demand for equipment and automation in North America and Asia. While top-line results exceeded expectations, adjusted EPS of $1.33 missed analyst consensus expectations of $1.37 by … Read more
10x Genomics Q2 Revenue Beats Expectations at $151 Million Despite Year-Over-Year Decline 10x Genomics reported second-quarter revenue of $151 million, beating analyst estimates of $146.5 million, according to company financial highlights. That revenue figure marks a 12.6% decline compared to the same period last year. Adjusted earnings per share reached $0.03, topping the consensus estimate … Read more
DraftKings (NASDAQ:DKNG) reported a revenue of $1.44 billion for the second quarter of 2026, a 4.6% year-over-year decline that missed analyst expectations of $1.51 billion. Despite the revenue miss and an adjusted earnings per share of $0.09—down 53.1% from consensus estimates—the company reconfirmed its full-year revenue guidance of $6.7 billion and raised its EBITDA outlook … Read more